The 400th procedure was a haploidentical allogeneic transplant for a patient with acute myeloid leukemia (AML), using stem cells donated by the patient’s daughter. Haploidentical transplants, requiring only a partial tissue-type match between donor and recipient, have broadened the scope of family-based donations, enhancing access for patients in need.
Of the 400 transplants, 220 were allogeneic, using donor stem cells, and 180 were autologous, employing the patient’s own cells. The primary conditions treated include acute myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndromes, all serious hematologic malignancies. The hospital has continually improved the safety and efficacy of its transplant program, drawing on extensive expertise in both pre- and post-transplant care.
Inha University Hospital operates a dedicated sterile ward for hematopoietic stem cell transplants, with two transplant beds and eight semi-sterile rooms, for a total of 10 beds. The ward is equipped with advanced infection control systems, including automated temperature and humidity regulation, cleanroom panels, and medical gas infrastructure, ensuring a secure environment for immunocompromised patients.
Dr. Taek Lee, president of Inha University Hospital, highlighted the procedure’s complexity, stating, “Hematopoietic stem cell transplantation requires successful chemotherapy, reliable donor availability, and close coordination with the medical team. We prioritize patient safety by carefully managing each stage of the process, aiming to provide dependable care for those battling serious blood disorders.”
Lim Hye Jung, HEALTH IN NEWS TEAM
press@hinews.co.kr
